Form 4 for ACRS Aclaris Therapeutics, Inc.
Accepted 2026-01-05 00:00:00 ET · period of report 2025-12-31 · accession 0001781549-26-000003 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-01-05 | 2025-12-31+ | ACRS | Loerop James | Chief Business Off | F - Tax | $2.99 | -40.2K | 143.1K | -22% | -$120.1K |
| DM | 2026-01-05 | 2025-12-31+ | ACRS | Loerop James | Chief Business Off | M - OptEx | — | +91.9K | 161.2K | +133% | — |
| DM | 2026-01-05 | 2025-12-31+ | ACRS | Loerop James | Chief Business Off | M - OptEx | $0.00 | -91.9K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-01-02 | F | D | 6,171 | $2.88 | 155,041 | D | — | — | |
| 2 | Common | Common Stock | 2025-12-31 | F | D | 33,994 | $3.01 | 143,062 | D | — | — | |
| 3 | Common | Common Stock | 2025-12-31 | M | A | 73,750 | — | 177,056 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. |
| 4 | Common | Common Stock | 2026-01-02 | M | A | 18,150 | — | 161,212 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. |
| 5 | Derivative | Restricted Stock Units | 2026-01-02 | M | D | 18,150 | $0.00 | 18,700 | D | — · — to — | 18,150 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. (F4) The shares underlying these restricted stock units vest as to 33% on January 2, 2025, 33% on January 2, 2026, and 34% on January 2, 2027, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of each such date. |
| 6 | Derivative | Restricted Stock Units | 2025-12-31 | M | D | 73,750 | $0.00 | 0 | D | — · — to — | 73,750 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. (F3) 50% of the shares underlying these restricted stock units vested on each of December 31, 2024 and December 31, 2025. |